Arkolith/Insider Trading/PRTK/Form 4

Bigham Michael

Exec. Chairman of the Board, DirectorParatek Pharmaceuticals, Inc. (PRTK) · full profile →Form 4 · filed Dec 22, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$31K
Net Open-Market Flow
-$31K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 21, 2022Sell(S)16K$1.99$31K1.2M
Dec 20, 2022Grant(A)45K—$01.2M

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000904454-22-000647) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML